# Zhiran Medical

Zhiran Medical is a company headquartered in Beijing, China.



Canonical: https://uniquebase.ai/companies/UB-C6110
Stable identifier: UB-C6110
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-15T17:35:38.188Z

## Funding

Listed 3 records.
Latest: RMB 600M (Equity), 2026-09-22.

- 2026-09-22 · RMB 600M (≈ $85.7M) · Equity · Hongshan China, Shunwei Capital, 中关村科学城公司, 中科创星, 丹麓资本, 佳银基金, 元生创投, 华盖资本, 君联资本, 国寿投资, 杏泽资本, 济峰资本, 美团龙珠, 顺禧基金
  > On September 22, 2026, Beijing-based Zhiran Medical, a next-generation flexible brain-computer interface platform developer, raised RMB 600 million from over ten investors including Shunxi Fund, Sequoia China, Junlian Capital, Shunwei Capital, Meituan Longzhu and CAS Star. It was founded by Dr. Song Qi. (translated source brief)
- 2026-02-11 · RMB 300M (≈ $42.9M) · Series A+ · BV, Hongshan China, IDG Capital, Shunwei Capital, 中科创星, 佳银基金, 元生创投, 君联资本, 杏泽资本, 美团龙珠, 联想创投, 顺禧基金
  > On 2026-02-11, according to Xiniu Data, Zhiran Medical completed Series A+ financing, raising RMB 300 million. Investors were Yuansheng Venture Capital, Junlian Capital, Hongshan China, Xingze Capital and others. (translated source brief)
- 2025-08-02 · RMB 300M (≈ $42.9M) · Series A · BV, IDG Capital, 元生创投, 君联资本, 国寿投资, 美团龙珠, 联想创投, 顺禧基金

## Valuation

Listed 3 records.

- 2026-09-22 · amount unavailable · Equity · Hongshan China, Shunwei Capital, 中关村科学城公司, 中科创星, 丹麓资本, 佳银基金, 元生创投, 华盖资本, 君联资本, 国寿投资, 杏泽资本, 济峰资本, 美团龙珠, 顺禧基金
  > On September 22, 2026, Beijing-based Zhiran Medical, a next-generation flexible brain-computer interface platform developer, raised RMB 600 million from over ten investors including Shunxi Fund, Sequoia China, Junlian Capital, Shunwei Capital, Meituan Longzhu and CAS Star. It was founded by Dr. Song Qi. (translated source brief)
- 2026-02-11 · amount unavailable · Series A+ · BV, Hongshan China, IDG Capital, Shunwei Capital, 中科创星, 佳银基金, 元生创投, 君联资本, 杏泽资本, 美团龙珠, 联想创投, 顺禧基金
  > On 2026-02-11, according to Xiniu Data, Zhiran Medical completed Series A+ financing, raising RMB 300 million. Investors were Yuansheng Venture Capital, Junlian Capital, Hongshan China, Xingze Capital and others. (translated source brief)
- 2025-08-02 · amount unavailable · Series A · BV, IDG Capital, 元生创投, 君联资本, 国寿投资, 美团龙珠, 联想创投, 顺禧基金

## Revenue

No revenue records are listed yet.


## Team

- [Fang Ying](/people/fang-ying)
- [Song Qi](/people/song-qi)

## Products

No published products profiles are linked yet.

## Investors

- [BV](/institutions/bv-baidufengtou)
- [Hongshan China](/institutions/hongshan-china)
- [IDG Capital](/institutions/idg-capital)
- [Shunwei Capital](/institutions/shunwei-capital)
- [中关村科学城公司](/institutions/zhongguancunkexuechenggongsi)
- [中科创星](/institutions/zhongkechuangxing)
- [丹麓资本](/institutions/danlu-capital)
- [佳银基金](/institutions/jiayin-fund)
- [元生创投](/institutions/yuansheng-venture-capital)
- [华盖资本](/institutions/huagai-capital)
- [君联资本](/institutions/junlian-capital)
- [国寿投资](/institutions/guoshou-investment)
- [杏泽资本](/institutions/xingze-capital)
- [济峰资本](/institutions/jifeng-capital)
- [美团龙珠](/institutions/meituanlongzhu)
- [联想创投](/institutions/lianxiang-venture-capital)
- [顺禧基金](/institutions/shunxi-fund)

## Sources

- No source links are available for this profile.